{"transactions":[{"id":709247,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-16T01:32:40.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":14150,"derivative":{"exercise_price":0.68,"exercise_date":"2027-07-09","expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001237419-26-000003","document":"form4-07162026_010736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000123741926000003/form4-07162026_010736.xml","form_type":"4"}},{"id":851709,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T23:21:59.000Z","date":"2026-03-08","kind":"grant","planned":false,"acquired":true,"shares":31258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof.  The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":31258,"derivative":{"exercise_price":1.6,"exercise_date":"2027-03-08","expiration_date":"2036-03-08","underlying":"Common Stock","underlying_shares":31258},"source":{"system":"sec-edgar","filing":"0001237419-26-000002","document":"form4-03102026_110356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000123741926000002/form4-03102026_110356.xml","form_type":"4"}},{"id":968030,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-16T23:21:50.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":19496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":19496,"derivative":{"exercise_price":2.33,"exercise_date":"2026-12-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":19496},"source":{"system":"sec-edgar","filing":"0001237419-25-000004","document":"form4-12162025_111247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000123741925000004/form4-12162025_111247.xml","form_type":"4"}},{"id":968029,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T23:21:50.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":4874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis."}],"balance_after":109222,"source":{"system":"sec-edgar","filing":"0001237419-25-000004","document":"form4-12162025_111247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000123741925000004/form4-12162025_111247.xml","form_type":"4"}},{"id":1018774,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-10-16T00:06:31.000Z","date":"2025-10-12","kind":"grant","planned":false,"acquired":true,"shares":11530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":11530,"derivative":{"exercise_price":3.01,"exercise_date":"2026-10-12","expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":11530},"source":{"system":"sec-edgar","filing":"0001237419-25-000003","document":"form4-10162025_121028.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000123741925000003/form4-10162025_121028.xml","form_type":"4"}},{"id":1104176,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-06-23T21:50:04.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":23000,"derivative":{"exercise_price":1.65,"exercise_date":"2026-06-19","expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001415889-25-017992","document":"form4-06232025_090600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588925017992/form4-06232025_090600.xml","form_type":"4"}},{"id":1261001,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Pre-Funded Warrant (right to buy)","published_at":"2025-02-19T23:23:35.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":false,"shares":96348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Pre-Funded Warrants became exercisable upon stockholder approval on February 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants do not expire."}],"balance_after":0,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":96348},"source":{"system":"sec-edgar","filing":"0001415889-25-004727","document":"form4-02192025_110231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588925004727/form4-02192025_110231.xml","form_type":"4"}},{"id":1261000,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-19T23:23:35.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":96348,"price":0.01,"value":963.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock was acquired by way of an exercise of Pre-Funded Warrants at an exercise price of $0.01 per Pre-Funded Warrant. The Pre-Funded warrants were acquired as part of Class B Units, with each Class B unit consisting of one Pre-Funded Warrant and one Series A Warrant, at a purchase price of $5.093 per Class B Unit."}],"balance_after":104348,"source":{"system":"sec-edgar","filing":"0001415889-25-004727","document":"form4-02192025_110231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588925004727/form4-02192025_110231.xml","form_type":"4"}},{"id":1294698,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Warrant (right to buy)","published_at":"2025-01-28T00:02:52.000Z","date":"2024-12-29","kind":"purchase","planned":false,"acquired":true,"shares":96348,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Pre-Funded Warrants and Series A Warrants were purchased as part of Class B Units, with each Class B Unit consisting of one Pre-Funded Warrant and one Series A Warrant, at a purchase price of $5.093 per Class B Unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A Warrants shall become exercisable on June 30, 2025; provided however, that the Series A Warrants may not be exercised prior to the issuer's receipt of stockholder approval of the exercise of the Series A Warrants, in accordance with Nasdaq listing rules."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Warrants shall expire on the date that is the earlier of (a) December 31, 2029, and (b) subject to the fulfilment of certain equity conditions, thirty trading days after the last of the following data readouts to occur, as announced by the issuer: (i) Ferret animal model Bird Flu data, (ii) non-human primate Bird Flu data, or (iii) Phase 2a Influenza A human clinical data."}],"balance_after":96348,"derivative":{"exercise_price":13.42,"underlying":"Common Stock","underlying_shares":96348},"source":{"system":"sec-edgar","filing":"0001104659-25-006408","document":"tm254427-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925006408/tm254427-3_4seq1.xml","form_type":"4"}},{"id":1294697,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Pre-Funded Warrant (right to buy)","published_at":"2025-01-28T00:02:52.000Z","date":"2024-12-29","kind":"purchase","planned":false,"acquired":true,"shares":96348,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Pre-Funded Warrants and Series A Warrants were purchased as part of Class B Units, with each Class B Unit consisting of one Pre-Funded Warrant and one Series A Warrant, at a purchase price of $5.093 per Class B Unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Pre-Funded Warrants shall become exercisable upon stockholder approval of the exercise of the Pre-Funded Warrants, in accordance with Nasdaq listing rules."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."}],"balance_after":96348,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":96348},"source":{"system":"sec-edgar","filing":"0001104659-25-006408","document":"tm254427-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925006408/tm254427-3_4seq1.xml","form_type":"4"}},{"id":1550718,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-04T00:03:08.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025.  Each restricted stock unit will convert into common stock of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.), par value $0.01 per share, on a one-for-one basis."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000929638-24-001362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000092963824001362/form4.xml","form_type":"4"}},{"id":4163601,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-15T02:57:55.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":20000,"price":9.3125,"value":186250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.20 to $9.50, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) of this Form 4."}],"balance_after":321203,"source":{"system":"sec-edgar","filing":"0001638599-17-001135","document":"doc4_5078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917001135/doc4_5078.xml","form_type":"4"}},{"id":4259038,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":30383,"kind":"person","name":"CAUTREELS WERNER","position":1,"cik":"0001237419","reported_name":"CAUTREELS WERNER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-11T20:44:58.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on June 16, 2018.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":19.33,"expiration_date":"2027-07-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001638599-17-000700","document":"doc4_4843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000700/doc4_4843.xml","form_type":"4"}}]}